198 related articles for article (PubMed ID: 15707407)
1. The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I.
Koyrakh L; Roman MI; Brinkmann V; Wickman K
Am J Transplant; 2005 Mar; 5(3):529-36. PubMed ID: 15707407
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels.
Qin X; Yue Z; Sun B; Yang W; Xie J; Ni E; Feng Y; Mahmood R; Zhang Y; Yue L
Br J Pharmacol; 2013 Mar; 168(6):1294-312. PubMed ID: 23145923
[TBL] [Abstract][Full Text] [Related]
3. HL-1 cells express an inwardly rectifying K+ current activated via muscarinic receptors comparable to that in mouse atrial myocytes.
Nobles M; Sebastian S; Tinker A
Pflugers Arch; 2010 Jun; 460(1):99-108. PubMed ID: 20186548
[TBL] [Abstract][Full Text] [Related]
4. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Choi JW; Gardell SE; Herr DR; Rivera R; Lee CW; Noguchi K; Teo ST; Yung YC; Lu M; Kennedy G; Chun J
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):751-6. PubMed ID: 21177428
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine-1-phosphate effects on guinea pig atrial myocytes: Alterations in action potentials and K+ currents.
Ochi R; Momose Y; Oyama K; Giles WR
Cardiovasc Res; 2006 Apr; 70(1):88-96. PubMed ID: 16545787
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes.
Landeen LK; Dederko DA; Kondo CS; Hu BS; Aroonsakool N; Haga JH; Giles WR
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H736-49. PubMed ID: 18024550
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
Oo ML; Thangada S; Wu MT; Liu CH; Macdonald TL; Lynch KR; Lin CY; Hla T
J Biol Chem; 2007 Mar; 282(12):9082-9. PubMed ID: 17237497
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
Butler J; Lana D; Round O; LaMontagne K
Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):29-45. PubMed ID: 15165029
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of acetylcholine-activated K(+) currents by U73122 is mediated by the inhibition of PIP(2)-channel interaction.
Cho H; Youm JB; Ryu SY; Earm YE; Ho WK
Br J Pharmacol; 2001 Nov; 134(5):1066-72. PubMed ID: 11682455
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the Kir3.1 subunit to the muscarinic-gated atrial potassium channel IKACh.
Bettahi I; Marker CL; Roman MI; Wickman K
J Biol Chem; 2002 Dec; 277(50):48282-8. PubMed ID: 12374786
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholine-induced phosphatidylinositol 4,5-bisphosphate depletion does not cause short-term desensitization of G protein-gated inwardly rectifying K+ current in mouse atrial myocytes.
Cho H; Hwang JY; Kim D; Shin HS; Kim Y; Earm YE; Ho WK
J Biol Chem; 2002 Aug; 277(31):27742-7. PubMed ID: 12019267
[TBL] [Abstract][Full Text] [Related]
13. [A new therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)].
Chiba K
Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):92-101. PubMed ID: 19404007
[TBL] [Abstract][Full Text] [Related]
14. Coordination of membrane excitability through a GIRK1 signaling complex in the atria.
Nikolov EN; Ivanova-Nikolova TT
J Biol Chem; 2004 May; 279(22):23630-6. PubMed ID: 15037627
[TBL] [Abstract][Full Text] [Related]
15. The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity.
Bandhuvula P; Tam YY; Oskouian B; Saba JD
J Biol Chem; 2005 Oct; 280(40):33697-700. PubMed ID: 16118221
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol 4,5-bisphosphate is acting as a signal molecule in alpha(1)-adrenergic pathway via the modulation of acetylcholine-activated K(+) channels in mouse atrial myocytes.
Cho H; Nam GB; Lee SH; Earm YE; Ho WK
J Biol Chem; 2001 Jan; 276(1):159-64. PubMed ID: 11029461
[TBL] [Abstract][Full Text] [Related]
17. Role of SREBP-1 in the development of parasympathetic dysfunction in the hearts of type 1 diabetic Akita mice.
Park HJ; Zhang Y; Du C; Welzig CM; Madias C; Aronovitz MJ; Georgescu SP; Naggar I; Wang B; Kim YB; Blaustein RO; Karas RH; Liao R; Mathews CE; Galper JB
Circ Res; 2009 Jul; 105(3):287-94. PubMed ID: 19423844
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720.
Zemann B; Kinzel B; Müller M; Reuschel R; Mechtcheriakova D; Urtz N; Bornancin F; Baumruker T; Billich A
Blood; 2006 Feb; 107(4):1454-8. PubMed ID: 16223773
[TBL] [Abstract][Full Text] [Related]
19. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function.
Brinkmann V; Cyster JG; Hla T
Am J Transplant; 2004 Jul; 4(7):1019-25. PubMed ID: 15196057
[TBL] [Abstract][Full Text] [Related]
20. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.
Kihara A; Igarashi Y
Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
